Related Experiment Video
Updated: Mar 10, 2026

09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.8K
Mixed Phenotype Acute Leukemia Presenting as Leukemia Cutis.
Geetha Narayanan1, M T Sugeeth1, Lali V Soman1
1Department of Medical Oncology, Regional Cancer Centre, Trivandrum 695011, India.
Case Reports in Medicine
|December 14, 2016
Summary
Leukemia cutis (LC), a rare skin manifestation of mixed phenotypic acute leukemia (MPAL), presented as widespread lesions in an adult. Treatment with chemotherapy led to complete resolution of skin lesions and bone marrow remission.
Area of Science:
- Hematology
- Dermatology
- Oncology
Background:
- Leukemia cutis (LC) involves leukemic cell infiltration of the skin, causing visible lesions.
- LC is frequently observed in congenital leukemia and acute myeloid leukemia.
- LC is infrequently reported in mixed phenotypic acute leukemia (MPAL).
Purpose of the Study:
- To report the first case of an adult patient with MPAL of the T/myeloid with monocytic differentiation presenting with leukemia cutis.
- To describe the clinical presentation, diagnosis, and treatment outcome of this rare condition.
Main Methods:
- A case study of an adult female patient presenting with generalized erythematous papular and nodular skin lesions.
- Diagnostic procedures included skin biopsy confirming leukemic infiltration and bone marrow aspiration revealing MPAL (T/myeloid with monocytic differentiation).
Main Results:
- The patient presented with extensive, clinically recognizable cutaneous lesions.
- Skin biopsy confirmed leukemic infiltration, and bone marrow aspiration diagnosed MPAL of the T/myeloid with monocytic differentiation lineage.
- Following chemotherapy with Hyper-CVAD, the patient achieved complete resolution of skin lesions and bone marrow remission after the first cycle.
Conclusions:
- This case represents the first documented instance of leukemia cutis in an adult with MPAL of the T/myeloid with monocytic differentiation.
- Chemotherapy demonstrated significant efficacy in treating both the cutaneous manifestations and the underlying hematologic malignancy.
Related Concept Videos
Disorders of Leukocytes
2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Bone Marrow Sampling and Transplants
2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

